RTResearcher profile · from public sources
Rong Tian
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
Lung Adenocarcinoma With Extramedullary Hematopoiesis on ¹⁸F-FDG PET/CT: A Diagnostic Pitfall in Staging18F-FDG PET/CT.
Clinical nuclear medicine, Nov 2026
Publication
Extensive Neurolymphomatosis as the Sole Site of Relapse in Mantle Cell Lymphoma.
Clinical nuclear medicine, Sept 2026
Publication
Deep learning-based PET/CT mixture-of-experts model for relapse risk stratification in relapsed/refractory classical hodgkin lymphoma: a multicenter study.
European journal of nuclear medicine and molecular imaging, Aug 2026
Publication
Partial Remission in Pediatric Relapsed Neuroblastoma After Multiple Cycle Low-Dose 211 At-MABG Therapy.
Clinical nuclear medicine, Jul 2026
Publication
Spatiotemporal voxel-wise concordance between 68Ga-FAPI and 18F-FDG PET/CT: association with pathologic response in esophageal squamous cell carcinoma receiving neoadjuvant chemoradiotherapy.
European journal of nuclear medicine and molecular imaging, May 2026
Publication
A deep learning PET/CT biomarker for early progression (POD24) and survival stratification in follicular lymphoma: a multicenter study.
European journal of nuclear medicine and molecular imaging, Mar 2026
Publication
First-in-human evaluation of [211At]YF2 in patients with metastatic castration-resistant prostate cancer.
European journal of nuclear medicine and molecular imaging, Feb 2026
Publication
Discovery of Novel Positron Emission Tomography Tracers for Poly(ADP-Ribose) Polymerase Imaging in Glioblastoma through Photocatalyzed 18F-Fluorination.
Molecular pharmaceutics, Jan 2026
Publication
Discovery of a novel tau PET tracer: Design, synthesis, radio-labeling, and preclinical evaluations.
European journal of medicinal chemistry, Jan 2026
Publication
68Ga-FAPI and 18F-FDG PET/CT for predicting pathologic response and progression-free survival in locally advanced esophageal squamous cell carcinoma treated with neoadjuvant chemoradiotherapy.
European journal of nuclear medicine and molecular imaging, Dec 2025
Publication
The Anti-Thyroglobulin Antibody Trajectory and Risk of Structural Recurrence in Patients With Papillary Thyroid Cancer.
Head & neck, Nov 2025
Publication
An explainable transformer model integrating PET and tabular data for histologic grading and prognosis of follicular lymphoma: a multi-institutional digital biopsy study.
European journal of nuclear medicine and molecular imaging, Jan 2025
Publication
Improving the Risk Prediction of the 2015 ATA Recurrence Risk Stratification in Papillary Thyroid Cancer.
The Journal of clinical endocrinology and metabolism, Jan 2025
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Bingwen Zou directly.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error